MDxHealth SA expected to post a loss of 19 cents a share - Earnings Preview
24/02/2025 21:43
* MDxHealth SA MDXH.OQ MDXH.O is expected to show a rise
in
quarterly revenue when it reports results on February 26 for
the period ending December 31 2024
* The Herstal Liege-based company is expected to report a
20.4% increase in revenue to $23.36 million from $19.4 million a
year ago, according to the mean estimate from 6 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for MDxHealth SA is for a
loss
of 19 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MDxHealth
SA is
$6.00, above its last closing price of $1.86.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2024 -0.28 -0.27 -0.40 Missed -48.1
Jun. 30 2024 -0.27 -0.26 -0.42 Missed -58.5
Mar. 31 2024 -0.31 -0.30 -0.31 Missed -3.3
Dec. 31 2023 -0.22 -0.11 -0.39 Missed -254.5
Sep. -0.21 -0.19 -0.40 Missed -108.3
30 2023
Jun. 30 2023 -0.25 -0.22 -0.30 Missed -37.6
Mar. 31 2023 -0.32 -0.32 -0.50 Missed -55
Dec. 31 2022 -0.67 -0.65 -1.10 Missed -68.4
This summary was machine generated February 24 at 21:43 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)